JP2016531305A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016531305A5 JP2016531305A5 JP2016543421A JP2016543421A JP2016531305A5 JP 2016531305 A5 JP2016531305 A5 JP 2016531305A5 JP 2016543421 A JP2016543421 A JP 2016543421A JP 2016543421 A JP2016543421 A JP 2016543421A JP 2016531305 A5 JP2016531305 A5 JP 2016531305A5
- Authority
- JP
- Japan
- Prior art keywords
- mother
- uric acid
- asphyxia
- sample
- eclampsia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 15
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 claims 6
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 claims 6
- 208000033300 perinatal asphyxia Diseases 0.000 claims 6
- 229940116269 uric acid Drugs 0.000 claims 6
- 201000011461 pre-eclampsia Diseases 0.000 claims 4
- 230000008774 maternal effect Effects 0.000 claims 3
- 206010003497 Asphyxia Diseases 0.000 claims 2
- 208000001362 Fetal Growth Retardation Diseases 0.000 claims 2
- 206010070538 Gestational hypertension Diseases 0.000 claims 2
- 201000005624 HELLP Syndrome Diseases 0.000 claims 2
- 208000002296 eclampsia Diseases 0.000 claims 2
- 208000030941 fetal growth restriction Diseases 0.000 claims 2
- 208000004104 gestational diabetes Diseases 0.000 claims 2
- 210000002826 placenta Anatomy 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 210000003296 saliva Anatomy 0.000 claims 2
- 206010070531 Foetal growth restriction Diseases 0.000 claims 1
- 206010036603 Premature rupture of membranes Diseases 0.000 claims 1
- 230000036772 blood pressure Effects 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 230000035487 diastolic blood pressure Effects 0.000 claims 1
- 238000005259 measurement Methods 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
- 230000035935 pregnancy Effects 0.000 claims 1
- 230000002028 premature Effects 0.000 claims 1
- 230000035488 systolic blood pressure Effects 0.000 claims 1
- 230000002485 urinary effect Effects 0.000 claims 1
- 210000002700 urine Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1316668.1 | 2013-09-19 | ||
| GBGB1316668.1A GB201316668D0 (en) | 2013-09-19 | 2013-09-19 | Diagnosis of foetal distress |
| PCT/EP2014/070053 WO2015040190A1 (en) | 2013-09-19 | 2014-09-19 | Diagnosis of foetal distress |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016531305A JP2016531305A (ja) | 2016-10-06 |
| JP2016531305A5 true JP2016531305A5 (https=) | 2017-09-07 |
| JP6456394B2 JP6456394B2 (ja) | 2019-01-23 |
Family
ID=49553104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016543421A Active JP6456394B2 (ja) | 2013-09-19 | 2014-09-19 | 胎児仮死の診断 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20160231306A1 (https=) |
| EP (1) | EP3047269B1 (https=) |
| JP (1) | JP6456394B2 (https=) |
| CA (1) | CA2922894C (https=) |
| DK (1) | DK3047269T3 (https=) |
| ES (1) | ES2687971T3 (https=) |
| GB (1) | GB201316668D0 (https=) |
| WO (1) | WO2015040190A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017178621A2 (en) | 2016-04-14 | 2017-10-19 | Morgan Innovation & Technology Ltd | Methods and devices for measuring the levels of analytes in body fluids |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0313828D0 (en) * | 2003-06-16 | 2003-07-23 | Owen Smith Brian D O | Salivary urate for diagnosis of pre-eclampsia |
-
2013
- 2013-09-19 GB GBGB1316668.1A patent/GB201316668D0/en not_active Ceased
-
2014
- 2014-09-19 EP EP14772109.6A patent/EP3047269B1/en active Active
- 2014-09-19 ES ES14772109.6T patent/ES2687971T3/es active Active
- 2014-09-19 DK DK14772109.6T patent/DK3047269T3/en active
- 2014-09-19 WO PCT/EP2014/070053 patent/WO2015040190A1/en not_active Ceased
- 2014-09-19 CA CA2922894A patent/CA2922894C/en active Active
- 2014-09-19 US US15/023,002 patent/US20160231306A1/en not_active Abandoned
- 2014-09-19 JP JP2016543421A patent/JP6456394B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Li et al. | An analysis of the differences between early and late preeclampsia with severe hypertension | |
| Hutcheon et al. | Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy | |
| Salako et al. | Serum albumin, creatinine, uric acid and hypertensive disorders of pregnancy | |
| Siribamrungwong et al. | Relation between acute kidney injury and pregnancy-related factors | |
| Asoglu et al. | Exposure of the developing heart to diabetic environment and early cardiac assessment: A review | |
| Risch et al. | High first-trimester maternal blood cystatin C levels despite normal serum creatinine predict pre-eclampsia in singleton pregnancies | |
| JP2010512781A5 (https=) | ||
| Al Ghazali et al. | Study of the clinical significance of serum albumin level in preeclampsia and in the detection of its severity | |
| Narang et al. | Prediction of pre-eclampsia at 11-14 weeks of pregnancy using mean arterial pressure, uterine artery Doppler and pregnancy-associated plasma protein-A | |
| JP2016531305A5 (https=) | ||
| RU2561060C1 (ru) | Способ диагностики преэклампсии у беременных с хронической артериальной гипертензией | |
| Rosales-Ortiz et al. | Adolescence and preeclampsia | |
| KR20220060615A (ko) | miR-155-5p 및 miR-1290-3p의 발현수준 비율을 이용한 임신중독증 진단 방법 | |
| Mallikarjuna et al. | Estimation of fetal weight in utero by Dawn’s formula and Johnson’s formula: a comparative study | |
| Kant et al. | Role of maternal serum lactate dehydrogenase as a biochemical marker in pre-eclampsia | |
| Chang et al. | Umbilical cord insertion abnormalities | |
| DG et al. | First trimester screening for preeclampsia and intrauterine growth restriction using uterine artery Doppler and maternal serum placental growth factor and pregnancy associated plasma protein-A | |
| Kliman et al. | The majority of miscarriages are caused by genetic abnormalities | |
| Costa et al. | Cord blood B-type natriuretic peptide levels in placental insufficiency: Correlation with fetal Doppler and pH at birth | |
| JP6456394B2 (ja) | 胎児仮死の診断 | |
| Sharma et al. | Uterine artery diastolic notch as a predictor of pregnancy induced hypertension | |
| Tsuchiya et al. | Increased pulsatility of the ductus venosus blood velocity in the first trimester is associated with the delivery of small for gestational age or low birth weight infants | |
| Hund et al. | PROGNOSIS Study: Prediction of Short-Term Outcome in Pregnant Women With Suspected Preeclampsia Study Using the Angiogenic Biomarkers sFlt-1/PlGF | |
| Singh et al. | Cystatin C is a better marker of renal dysfunction in hypertensive pregnancies | |
| Dawood et al. | Which can predict Pregnancy-induced Insulin Resistance and Gestational Diabetes Mellitus; Glycated Albumin or Glycated Hemoglobin? |